Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516578 (US11053243, Example 189b | methyl [(2S)-1-{(2S)-2-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.00100 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM50147212 (CHEMBL3765311 | US11053243, Example 192) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | CHEMBL PC cid PC sid UniChem Similars | US Patent | n/a | n/a | n/a | n/a | 0.00200 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516573 (US11053243, Example 159 | tert-butyl {(1R)-2-[(2S)...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.00200 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516574 (US11053243, Example 169 | tert-butyl {(1R)-2-[(2S)...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.00400 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516583 (US11053243, Example 203) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.00400 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516552 ((2S,2'S)-N,N'-6,11-dihydro-5H- benzo[a]carbazole-3...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.00600 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516568 (US11053243, Example 137 | tert-butyl {(1R)-2-[(2S)...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.00900 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516584 (US11053243, Example 213) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.00900 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516553 ((2S,2'S)-N,N'-5,6,7,12- tetrahydrobenzo[6,7]cycloh...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0100 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516563 (US11053243, Example 119 | propan-2-yl [(1R)-2-oxo-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0130 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516576 (US11053243, Example 186 | tert-butyl {(1S)-2-[(2S)...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0150 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516554 (N-(6,11-dihydro-5H- benzo[a]carbazol-3-yl)-1-{(2S)...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0150 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516564 (US11053243, Example 125 | tert-butyl [(1R)-2-{(2S)...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0160 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516580 (US11053243, Example 191) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516546 ((2S)-1-[(2R)-2-phenyl-2- (pyrrolidin-1-yl)acetyl]-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0200 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516543 (US11053243, Example 40 | di-tert-butyl (1H,1′...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0260 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516556 (US11053243, Example 100 | benzyl (2S)-2-[5-(4-{5-[...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0310 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516570 (US11053243, Example 144 | tert-butyl (2S)-2-[(3-fl...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0360 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516555 (US11053243, Example 99 | tert-butyl {(1R)-2-[(2S)-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0380 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516561 (US11053243, Example 107 | tert-butyl {(1R)-2-[(2S)...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0400 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516538 (US11053243, Example 15 | tert-butyl {(1R)-2-[(2S)-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0450 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516544 (US11053243, Example 41 | tert-butyl {(1R)-2-oxo-1-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516582 ((2R)-2-(diethylamino)-1- [(2S)-2-(5-{4-[5-(2-{(2S)...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516566 (US11053243, Example 130 | tert-butyl {(1S)-2-[(2S)...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0500 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516540 ((2S)-1-[(2R)-2-(diethylamino)-2- phenylacetyl]-N-(...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0630 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516562 (N-(methoxycarbonyl)-L-valyl-N- {2-[4-(2-{(2S)-1-[N...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0650 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516550 ((2S)-1-[(2R)-2-(diethylamino)-2- phenylacetyl]-N-(...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0670 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516579 (US11053243, Example 190) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0670 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516547 ((2S)-1-(2,3-diphenylpropanoyl)- N-{4-[5-({[(2S)-1-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0720 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516560 (US11053243, Example 105 | tert-butyl{(1R)-2-[(2S)-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.0800 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM244736 (US10226449, cpd 346 | US9428502, 346) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.100 | n/a | n/a | n/a | n/a |
Conforma Therapeutics Corporation | Assay Description The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c... | J Med Chem 49: 5352-62 (2006) BindingDB Entry DOI: 10.7270/Q27M0B78 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516549 ((2S)-1-[(2R)-2phenyl-2- (piperidin-1-yl)acetyl]-N-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.130 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516577 (US11053243, Example 189a | methyl [(2S)-1-{(2S)-2-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.150 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516551 ((2S)-1-[(2R)-2-(dimethylamino)- 2-phenylacetyl]-N-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.170 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516542 ((2S,2′S) N,N′,1H,1′H-2,2′-...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.240 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516572 (US11053243, Example 158 | tert-butyl {(1R)-2-[(2S)...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516557 (1-[(2R)-2-(dimethylamino)-2- phenylacetyl]-N-{2-[4...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.5 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516565 ((2S)-N-{4-[3-fluoro-5-({[(2S)-1- (phenylacetyl)pyr...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.700 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516571 ((2S) N-{4-[3-cyano-5-({[(2S)-1-(phenylacetyl)pyrro...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.900 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM516548 (N-{2-[4-(acetylamino)phenyl]- 1H-indol-5-yl}-1[(2R...) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 0.970 | n/a | n/a | n/a | n/a |
TBA | Assay Description Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m... | Citation and Details BindingDB Entry DOI: 10.7270/Q2WW7MVZ | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM244563 (US10226449, cpd 172 | US9428502, 172) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Conforma Therapeutics Corporation | Assay Description The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c... | J Med Chem 49: 5352-62 (2006) BindingDB Entry DOI: 10.7270/Q27M0B78 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM244632 (US10226449, cpd 241 | US9428502, 241) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <1 | n/a | n/a | n/a | n/a |
Conforma Therapeutics Corporation | Assay Description The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c... | J Med Chem 49: 5352-62 (2006) BindingDB Entry DOI: 10.7270/Q27M0B78 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM244629 (US10226449, cpd 238 | US9428502, 238) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Conforma Therapeutics Corporation | Assay Description The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c... | J Med Chem 49: 5352-62 (2006) BindingDB Entry DOI: 10.7270/Q27M0B78 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C virus (HCV genotype 1a, isolate H)) | BDBM65581 (US9693997, 1) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
HOFFMANN-LA ROCHE INC. US Patent | Assay Description Plasmids expressing HCV E1 and E2 envelope proteins of GT1a H77 strain (Proc Natl Acad Sci USA 1997 94:8738-43) or GT1b Con1 strain (Science 1999 285... | US Patent US9693997 (2017) BindingDB Entry DOI: 10.7270/Q2833Q56 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM244568 (US10226449, cpd 177 | US9428502, 177) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 1 | n/a | n/a | n/a | n/a |
Conforma Therapeutics Corporation | Assay Description The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c... | J Med Chem 49: 5352-62 (2006) BindingDB Entry DOI: 10.7270/Q27M0B78 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM244559 (US10226449, cpd 168 | US9428502, 168) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Conforma Therapeutics Corporation | Assay Description The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c... | J Med Chem 49: 5352-62 (2006) BindingDB Entry DOI: 10.7270/Q27M0B78 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM244555 (US10226449, cpd 164 | US9428502, 164) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Conforma Therapeutics Corporation | Assay Description The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c... | J Med Chem 49: 5352-62 (2006) BindingDB Entry DOI: 10.7270/Q27M0B78 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM244738 (US10226449, cpd 348 | US9428502, 348) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Conforma Therapeutics Corporation | Assay Description The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c... | J Med Chem 49: 5352-62 (2006) BindingDB Entry DOI: 10.7270/Q27M0B78 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM244624 (US10226449, cpd 233 | US9428502, 233) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Conforma Therapeutics Corporation | Assay Description The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c... | J Med Chem 49: 5352-62 (2006) BindingDB Entry DOI: 10.7270/Q27M0B78 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Genome polyprotein (Hepatitis C Virus (Virus)) | BDBM244622 (US10226449, cpd 231 | US9428502, 231) | PDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2 | n/a | n/a | n/a | n/a |
Conforma Therapeutics Corporation | Assay Description The antiviral activities of the compounds were assessed using the HCV1b replicon system. The replicon was constructed using the ET (luc-ubi-neo/ET) c... | J Med Chem 49: 5352-62 (2006) BindingDB Entry DOI: 10.7270/Q27M0B78 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 675 total ) | Next | Last >> |